The data of patients with pancreatic cancer were obtained from the cancer genome atlas (TCGA) database ((https://portal.gdc.cancer.gov/) and used to evaluate the effect of PAR1 and FAK in patients with pancreatic cancer. This evidence concerns the gene F2R and familial pancreatic carcinoma.